Global Nuclear Receptor ROR Gamma Market Research Report 2021

Publisher Name :
Date: 04-Feb-2021
No. of pages: 116
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- BBI-6000

- GRC-39815Action

- R&D Progress

- GSK-2981278

- IMU-366

- INV-17

- Others

Segment by Application

- Chronic Obstructive Pulmonary Disease

- Asthma

- Axial Spondyloarthritis

- Breast Cancer

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

By Company

- Genfit SA

- GlaxoSmithKline Plc

- Aurigene Discovery Technologies

- Beijing Hanmi Pharmaceutical

- Biogen Inc

- AbbVie Inc

- Eurofins Advinus

- Brickell Biotech Inc

- Pfizer Inc

- Phenex Pharmaceuticals AG

- Reata Pharmaceuticals Inc

- Bristol-Myers Squibb Company

- Celgene Corp

- Eli Lilly

- Glenmark Pharmaceuticals

- Lead Pharma Holding BV

Global Nuclear Receptor ROR Gamma Market Research Report 2021

Table of Contents
1 Nuclear Receptor ROR Gamma Market Overview
1.1 Product Overview and Scope of Nuclear Receptor ROR Gamma
1.2 Nuclear Receptor ROR Gamma Segment by Type
1.2.1 Global Nuclear Receptor ROR Gamma Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 BBI-6000
1.2.3 GRC-39815Action
1.2.4 R&D Progress
1.2.5 GSK-2981278
1.2.6 IMU-366
1.2.7 INV-17
1.2.8 Others
1.3 Nuclear Receptor ROR Gamma Segment by Application
1.3.1 Nuclear Receptor ROR Gamma Sales Comparison by Application: (2021-2027)
1.3.2 Chronic Obstructive Pulmonary Disease
1.3.3 Asthma
1.3.4 Axial Spondyloarthritis
1.3.5 Breast Cancer
1.3.6 Others
1.4 Global Nuclear Receptor ROR Gamma Market Size Estimates and Forecasts
1.4.1 Global Nuclear Receptor ROR Gamma Revenue 2016-2027
1.4.2 Global Nuclear Receptor ROR Gamma Sales 2016-2027
1.4.3 Nuclear Receptor ROR Gamma Market Size by Region: 2016 Versus 2021 Versus 2027
2 Nuclear Receptor ROR Gamma Market Competition by Manufacturers
2.1 Global Nuclear Receptor ROR Gamma Sales Market Share by Manufacturers (2016-2021)
2.2 Global Nuclear Receptor ROR Gamma Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Nuclear Receptor ROR Gamma Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Nuclear Receptor ROR Gamma Manufacturing Sites, Area Served, Product Type
2.5 Nuclear Receptor ROR Gamma Market Competitive Situation and Trends
2.5.1 Nuclear Receptor ROR Gamma Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Nuclear Receptor ROR Gamma Players Market Share by Revenue
2.5.3 Global Nuclear Receptor ROR Gamma Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Nuclear Receptor ROR Gamma Retrospective Market Scenario by Region
3.1 Global Nuclear Receptor ROR Gamma Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Nuclear Receptor ROR Gamma Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Nuclear Receptor ROR Gamma Market Facts & Figures by Country
3.3.1 North America Nuclear Receptor ROR Gamma Sales by Country
3.3.2 North America Nuclear Receptor ROR Gamma Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Nuclear Receptor ROR Gamma Market Facts & Figures by Country
3.4.1 Europe Nuclear Receptor ROR Gamma Sales by Country
3.4.2 Europe Nuclear Receptor ROR Gamma Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Nuclear Receptor ROR Gamma Market Facts & Figures by Region
3.5.1 Asia Pacific Nuclear Receptor ROR Gamma Sales by Region
3.5.2 Asia Pacific Nuclear Receptor ROR Gamma Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Nuclear Receptor ROR Gamma Market Facts & Figures by Country
3.6.1 Latin America Nuclear Receptor ROR Gamma Sales by Country
3.6.2 Latin America Nuclear Receptor ROR Gamma Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Nuclear Receptor ROR Gamma Market Facts & Figures by Country
3.7.1 Middle East and Africa Nuclear Receptor ROR Gamma Sales by Country
3.7.2 Middle East and Africa Nuclear Receptor ROR Gamma Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Nuclear Receptor ROR Gamma Historic Market Analysis by Type
4.1 Global Nuclear Receptor ROR Gamma Sales Market Share by Type (2016-2021)
4.2 Global Nuclear Receptor ROR Gamma Revenue Market Share by Type (2016-2021)
4.3 Global Nuclear Receptor ROR Gamma Price by Type (2016-2021)
5 Global Nuclear Receptor ROR Gamma Historic Market Analysis by Application
5.1 Global Nuclear Receptor ROR Gamma Sales Market Share by Application (2016-2021)
5.2 Global Nuclear Receptor ROR Gamma Revenue Market Share by Application (2016-2021)
5.3 Global Nuclear Receptor ROR Gamma Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Genfit SA
6.1.1 Genfit SA Corporation Information
6.1.2 Genfit SA Description and Business Overview
6.1.3 Genfit SA Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Genfit SA Product Portfolio
6.1.5 Genfit SA Recent Developments/Updates
6.2 GlaxoSmithKline Plc
6.2.1 GlaxoSmithKline Plc Corporation Information
6.2.2 GlaxoSmithKline Plc Description and Business Overview
6.2.3 GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2016-2021)
6.2.4 GlaxoSmithKline Plc Product Portfolio
6.2.5 GlaxoSmithKline Plc Recent Developments/Updates
6.3 Aurigene Discovery Technologies
6.3.1 Aurigene Discovery Technologies Corporation Information
6.3.2 Aurigene Discovery Technologies Description and Business Overview
6.3.3 Aurigene Discovery Technologies Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Aurigene Discovery Technologies Product Portfolio
6.3.5 Aurigene Discovery Technologies Recent Developments/Updates
6.4 Beijing Hanmi Pharmaceutical
6.4.1 Beijing Hanmi Pharmaceutical Corporation Information
6.4.2 Beijing Hanmi Pharmaceutical Description and Business Overview
6.4.3 Beijing Hanmi Pharmaceutical Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Beijing Hanmi Pharmaceutical Product Portfolio
6.4.5 Beijing Hanmi Pharmaceutical Recent Developments/Updates
6.5 Biogen Inc
6.5.1 Biogen Inc Corporation Information
6.5.2 Biogen Inc Description and Business Overview
6.5.3 Biogen Inc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Biogen Inc Product Portfolio
6.5.5 Biogen Inc Recent Developments/Updates
6.6 AbbVie Inc
6.6.1 AbbVie Inc Corporation Information
6.6.2 AbbVie Inc Description and Business Overview
6.6.3 AbbVie Inc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2016-2021)
6.6.4 AbbVie Inc Product Portfolio
6.6.5 AbbVie Inc Recent Developments/Updates
6.7 Eurofins Advinus
6.6.1 Eurofins Advinus Corporation Information
6.6.2 Eurofins Advinus Description and Business Overview
6.6.3 Eurofins Advinus Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Eurofins Advinus Product Portfolio
6.7.5 Eurofins Advinus Recent Developments/Updates
6.8 Brickell Biotech Inc
6.8.1 Brickell Biotech Inc Corporation Information
6.8.2 Brickell Biotech Inc Description and Business Overview
6.8.3 Brickell Biotech Inc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Brickell Biotech Inc Product Portfolio
6.8.5 Brickell Biotech Inc Recent Developments/Updates
6.9 Pfizer Inc
6.9.1 Pfizer Inc Corporation Information
6.9.2 Pfizer Inc Description and Business Overview
6.9.3 Pfizer Inc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Pfizer Inc Product Portfolio
6.9.5 Pfizer Inc Recent Developments/Updates
6.10 Phenex Pharmaceuticals AG
6.10.1 Phenex Pharmaceuticals AG Corporation Information
6.10.2 Phenex Pharmaceuticals AG Description and Business Overview
6.10.3 Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Phenex Pharmaceuticals AG Product Portfolio
6.10.5 Phenex Pharmaceuticals AG Recent Developments/Updates
6.11 Reata Pharmaceuticals Inc
6.11.1 Reata Pharmaceuticals Inc Corporation Information
6.11.2 Reata Pharmaceuticals Inc Nuclear Receptor ROR Gamma Description and Business Overview
6.11.3 Reata Pharmaceuticals Inc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Reata Pharmaceuticals Inc Product Portfolio
6.11.5 Reata Pharmaceuticals Inc Recent Developments/Updates
6.12 Bristol-Myers Squibb Company
6.12.1 Bristol-Myers Squibb Company Corporation Information
6.12.2 Bristol-Myers Squibb Company Nuclear Receptor ROR Gamma Description and Business Overview
6.12.3 Bristol-Myers Squibb Company Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Bristol-Myers Squibb Company Product Portfolio
6.12.5 Bristol-Myers Squibb Company Recent Developments/Updates
6.13 Celgene Corp
6.13.1 Celgene Corp Corporation Information
6.13.2 Celgene Corp Nuclear Receptor ROR Gamma Description and Business Overview
6.13.3 Celgene Corp Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Celgene Corp Product Portfolio
6.13.5 Celgene Corp Recent Developments/Updates
6.14 Eli Lilly
6.14.1 Eli Lilly Corporation Information
6.14.2 Eli Lilly Nuclear Receptor ROR Gamma Description and Business Overview
6.14.3 Eli Lilly Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Eli Lilly Product Portfolio
6.14.5 Eli Lilly Recent Developments/Updates
6.15 Glenmark Pharmaceuticals
6.15.1 Glenmark Pharmaceuticals Corporation Information
6.15.2 Glenmark Pharmaceuticals Nuclear Receptor ROR Gamma Description and Business Overview
6.15.3 Glenmark Pharmaceuticals Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Glenmark Pharmaceuticals Product Portfolio
6.15.5 Glenmark Pharmaceuticals Recent Developments/Updates
6.16 Lead Pharma Holding BV
6.16.1 Lead Pharma Holding BV Corporation Information
6.16.2 Lead Pharma Holding BV Nuclear Receptor ROR Gamma Description and Business Overview
6.16.3 Lead Pharma Holding BV Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Lead Pharma Holding BV Product Portfolio
6.16.5 Lead Pharma Holding BV Recent Developments/Updates
7 Nuclear Receptor ROR Gamma Manufacturing Cost Analysis
7.1 Nuclear Receptor ROR Gamma Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Nuclear Receptor ROR Gamma
7.4 Nuclear Receptor ROR Gamma Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Nuclear Receptor ROR Gamma Distributors List
8.3 Nuclear Receptor ROR Gamma Customers
9 Nuclear Receptor ROR Gamma Market Dynamics
9.1 Nuclear Receptor ROR Gamma Industry Trends
9.2 Nuclear Receptor ROR Gamma Growth Drivers
9.3 Nuclear Receptor ROR Gamma Market Challenges
9.4 Nuclear Receptor ROR Gamma Market Restraints
10 Global Market Forecast
10.1 Nuclear Receptor ROR Gamma Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Nuclear Receptor ROR Gamma by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Nuclear Receptor ROR Gamma by Type (2022-2027)
10.2 Nuclear Receptor ROR Gamma Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Nuclear Receptor ROR Gamma by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Nuclear Receptor ROR Gamma by Application (2022-2027)
10.3 Nuclear Receptor ROR Gamma Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Nuclear Receptor ROR Gamma by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Nuclear Receptor ROR Gamma by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Nuclear Receptor ROR Gamma Sales (K Pcs) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Nuclear Receptor ROR Gamma Sales (K Pcs) Comparison by Application (2021-2027)
Table 3. Global Nuclear Receptor ROR Gamma Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Nuclear Receptor ROR Gamma Covered in This Study
Table 5. Global Nuclear Receptor ROR Gamma Sales (K Pcs) of Key Manufacturers (2016-2021)
Table 6. Global Nuclear Receptor ROR Gamma Sales Share by Manufacturers (2016-2021)
Table 7. Global Nuclear Receptor ROR Gamma Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Nuclear Receptor ROR Gamma Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Nuclear Receptor ROR Gamma Average Price (USD/Pcs) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Nuclear Receptor ROR Gamma Manufacturing Sites and Area Served
Table 11. Manufacturers Nuclear Receptor ROR Gamma Product Type
Table 12. Global Nuclear Receptor ROR Gamma Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Nuclear Receptor ROR Gamma by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Receptor ROR Gamma as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Nuclear Receptor ROR Gamma Sales by Region (2016-2021) & (K Pcs)
Table 16. Global Nuclear Receptor ROR Gamma Sales Market Share by Region (2016-2021)
Table 17. Global Nuclear Receptor ROR Gamma Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Nuclear Receptor ROR Gamma Sales by Country (2016-2021) & (K Pcs)
Table 19. North America Nuclear Receptor ROR Gamma Sales Market Share by Country (2016-2021)
Table 20. North America Nuclear Receptor ROR Gamma Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Nuclear Receptor ROR Gamma Revenue Market Share by Country (2016-2021)
Table 22. Europe Nuclear Receptor ROR Gamma Sales by Country (2016-2021) & (K Pcs)
Table 23. Europe Nuclear Receptor ROR Gamma Sales Market Share by Country (2016-2021)
Table 24. Europe Nuclear Receptor ROR Gamma Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Nuclear Receptor ROR Gamma Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Nuclear Receptor ROR Gamma Sales by Region (2016-2021) & (K Pcs)
Table 27. Asia Pacific Nuclear Receptor ROR Gamma Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Nuclear Receptor ROR Gamma Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Nuclear Receptor ROR Gamma Revenue Market Share by Region (2016-2021)
Table 30. Latin America Nuclear Receptor ROR Gamma Sales by Country (2016-2021) & (K Pcs)
Table 31. Latin America Nuclear Receptor ROR Gamma Sales Market Share by Country (2016-2021)
Table 32. Latin America Nuclear Receptor ROR Gamma Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Nuclear Receptor ROR Gamma Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Nuclear Receptor ROR Gamma Sales by Country (2016-2021) & (K Pcs)
Table 35. Middle East and Africa Nuclear Receptor ROR Gamma Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Nuclear Receptor ROR Gamma Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Nuclear Receptor ROR Gamma Revenue Market Share by Country (2016-2021)
Table 38. Global Nuclear Receptor ROR Gamma Sales (K Pcs) by Type (2016-2021)
Table 39. Global Nuclear Receptor ROR Gamma Sales Market Share by Type (2016-2021)
Table 40. Global Nuclear Receptor ROR Gamma Revenue (Million US$) by Type (2016-2021)
Table 41. Global Nuclear Receptor ROR Gamma Revenue Share by Type (2016-2021)
Table 42. Global Nuclear Receptor ROR Gamma Price (USD/Pcs) by Type (2016-2021)
Table 43. Global Nuclear Receptor ROR Gamma Sales (K Pcs) by Application (2016-2021)
Table 44. Global Nuclear Receptor ROR Gamma Sales Market Share by Application (2016-2021)
Table 45. Global Nuclear Receptor ROR Gamma Revenue (Million US$) by Application (2016-2021)
Table 46. Global Nuclear Receptor ROR Gamma Revenue Share by Application (2016-2021)
Table 47. Global Nuclear Receptor ROR Gamma Price (USD/Pcs) by Application (2016-2021)
Table 48. Genfit SA Corporation Information
Table 49. Genfit SA Description and Business Overview
Table 50. Genfit SA Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 51. Genfit SA Nuclear Receptor ROR Gamma Product
Table 52. Genfit SA Recent Developments/Updates
Table 53. GlaxoSmithKline Plc Corporation Information
Table 54. GlaxoSmithKline Plc Description and Business Overview
Table 55. GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 56. GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Product
Table 57. GlaxoSmithKline Plc Recent Developments/Updates
Table 58. Aurigene Discovery Technologies Corporation Information
Table 59. Aurigene Discovery Technologies Description and Business Overview
Table 60. Aurigene Discovery Technologies Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 61. Aurigene Discovery Technologies Nuclear Receptor ROR Gamma Product
Table 62. Aurigene Discovery Technologies Recent Developments/Updates
Table 63. Beijing Hanmi Pharmaceutical Corporation Information
Table 64. Beijing Hanmi Pharmaceutical Description and Business Overview
Table 65. Beijing Hanmi Pharmaceutical Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 66. Beijing Hanmi Pharmaceutical Nuclear Receptor ROR Gamma Product
Table 67. Beijing Hanmi Pharmaceutical Recent Developments/Updates
Table 68. Biogen Inc Corporation Information
Table 69. Biogen Inc Description and Business Overview
Table 70. Biogen Inc Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 71. Biogen Inc Nuclear Receptor ROR Gamma Product
Table 72. Biogen Inc Recent Developments/Updates
Table 73. AbbVie Inc Corporation Information
Table 74. AbbVie Inc Description and Business Overview
Table 75. AbbVie Inc Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 76. AbbVie Inc Nuclear Receptor ROR Gamma Product
Table 77. AbbVie Inc Recent Developments/Updates
Table 78. Eurofins Advinus Corporation Information
Table 79. Eurofins Advinus Description and Business Overview
Table 80. Eurofins Advinus Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 81. Eurofins Advinus Nuclear Receptor ROR Gamma Product
Table 82. Eurofins Advinus Recent Developments/Updates
Table 83. Brickell Biotech Inc Corporation Information
Table 84. Brickell Biotech Inc Description and Business Overview
Table 85. Brickell Biotech Inc Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 86. Brickell Biotech Inc Nuclear Receptor ROR Gamma Product
Table 87. Brickell Biotech Inc Recent Developments/Updates
Table 88. Pfizer Inc Corporation Information
Table 89. Pfizer Inc Description and Business Overview
Table 90. Pfizer Inc Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 91. Pfizer Inc Nuclear Receptor ROR Gamma Product
Table 92. Pfizer Inc Recent Developments/Updates
Table 93. Phenex Pharmaceuticals AG Corporation Information
Table 94. Phenex Pharmaceuticals AG Description and Business Overview
Table 95. Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 96. Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Product
Table 97. Phenex Pharmaceuticals AG Recent Developments/Updates
Table 98. Reata Pharmaceuticals Inc Corporation Information
Table 99. Reata Pharmaceuticals Inc Description and Business Overview
Table 100. Reata Pharmaceuticals Inc Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 101. Reata Pharmaceuticals Inc Nuclear Receptor ROR Gamma Product
Table 102. Reata Pharmaceuticals Inc Recent Developments/Updates
Table 103. Bristol-Myers Squibb Company Corporation Information
Table 104. Bristol-Myers Squibb Company Description and Business Overview
Table 105. Bristol-Myers Squibb Company Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 106. Bristol-Myers Squibb Company Nuclear Receptor ROR Gamma Product
Table 107. Bristol-Myers Squibb Company Recent Developments/Updates
Table 108. Celgene Corp Corporation Information
Table 109. Celgene Corp Description and Business Overview
Table 110. Celgene Corp Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 111. Celgene Corp Nuclear Receptor ROR Gamma Product
Table 112. Celgene Corp Recent Developments/Updates
Table 113. Eli Lilly Corporation Information
Table 114. Eli Lilly Description and Business Overview
Table 115. Eli Lilly Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 116. Eli Lilly Nuclear Receptor ROR Gamma Product
Table 117. Eli Lilly Recent Developments/Updates
Table 118. Glenmark Pharmaceuticals Corporation Information
Table 119. Glenmark Pharmaceuticals Description and Business Overview
Table 120. Glenmark Pharmaceuticals Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 121. Glenmark Pharmaceuticals Nuclear Receptor ROR Gamma Product
Table 122. Glenmark Pharmaceuticals Recent Developments/Updates
Table 123. Lead Pharma Holding BV Corporation Information
Table 124. Lead Pharma Holding BV Description and Business Overview
Table 125. Lead Pharma Holding BV Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 126. Lead Pharma Holding BV Nuclear Receptor ROR Gamma Product
Table 127. Lead Pharma Holding BV Recent Developments/Updates
Table 128. Production Base and Market Concentration Rate of Raw Material
Table 129. Key Suppliers of Raw Materials
Table 130. Nuclear Receptor ROR Gamma Distributors List
Table 131. Nuclear Receptor ROR Gamma Customers List
Table 132. Nuclear Receptor ROR Gamma Market Trends
Table 133. Nuclear Receptor ROR Gamma Growth Drivers
Table 134. Nuclear Receptor ROR Gamma Market Restraints
Table 135. Global Nuclear Receptor ROR Gamma Sales Forecast by Type (2022-2027) & (K Pcs)
Table 136. Global Nuclear Receptor ROR Gamma Sales Market Share Forecast by Type (2022-2027)
Table 137. Global Nuclear Receptor ROR Gamma Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 138. Global Nuclear Receptor ROR Gamma Revenue Market Share Forecast by Type (2022-2027)
Table 139. Global Nuclear Receptor ROR Gamma Sales Forecast by Application (2022-2027) & (K Pcs)
Table 140. Global Nuclear Receptor ROR Gamma Sales Market Share Forecast by Application (2022-2027)
Table 141. Global Nuclear Receptor ROR Gamma Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 142. Global Nuclear Receptor ROR Gamma Revenue Market Share Forecast by Application (2022-2027)
Table 143. Global Nuclear Receptor ROR Gamma Sales Forecast by Region (2022-2027) & (K Pcs)
Table 144. Global Nuclear Receptor ROR Gamma Sales Market Share Forecast by Region (2022-2027)
Table 145. Global Nuclear Receptor ROR Gamma Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 146. Global Nuclear Receptor ROR Gamma Revenue Market Share Forecast by Region (2022-2027)
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Nuclear Receptor ROR Gamma
Figure 2. Global Nuclear Receptor ROR Gamma Market Share by Type in 2020 & 2027
Figure 3. BBI-6000 Product Picture
Figure 4. GRC-39815Action Product Picture
Figure 5. R&D Progress Product Picture
Figure 6. GSK-2981278 Product Picture
Figure 7. IMU-366 Product Picture
Figure 8. INV-17 Product Picture
Figure 9. Others Product Picture
Figure 10. Global Nuclear Receptor ROR Gamma Market Share by Application in 2020 & 2027
Figure 11. Chronic Obstructive Pulmonary Disease
Figure 12. Asthma
Figure 13. Axial Spondyloarthritis
Figure 14. Breast Cancer
Figure 15. Others
Figure 16. Global Nuclear Receptor ROR Gamma Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Nuclear Receptor ROR Gamma Market Size 2016-2027 (US$ Million)
Figure 18. Global Nuclear Receptor ROR Gamma Sales 2016-2027 (K Pcs)
Figure 19. Global Nuclear Receptor ROR Gamma Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 20. Nuclear Receptor ROR Gamma Sales Share by Manufacturers in 2020
Figure 21. Global Nuclear Receptor ROR Gamma Revenue Share by Manufacturers in 2020
Figure 22. The Global 5 and 10 Largest Nuclear Receptor ROR Gamma Players: Market Share by Revenue in 2020
Figure 23. Nuclear Receptor ROR Gamma Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 24. Global Nuclear Receptor ROR Gamma Sales Market Share by Region (2016-2021)
Figure 25. Global Nuclear Receptor ROR Gamma Sales Market Share by Region in 2020
Figure 26. Global Nuclear Receptor ROR Gamma Revenue Market Share by Region (2016-2021)
Figure 27. Global Nuclear Receptor ROR Gamma Revenue Market Share by Region in 2020
Figure 28. U.S. Nuclear Receptor ROR Gamma Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Canada Nuclear Receptor ROR Gamma Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Germany Nuclear Receptor ROR Gamma Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. France Nuclear Receptor ROR Gamma Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. U.K. Nuclear Receptor ROR Gamma Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Italy Nuclear Receptor ROR Gamma Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Russia Nuclear Receptor ROR Gamma Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. China Nuclear Receptor ROR Gamma Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Japan Nuclear Receptor ROR Gamma Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. South Korea Nuclear Receptor ROR Gamma Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. India Nuclear Receptor ROR Gamma Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Australia Nuclear Receptor ROR Gamma Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Taiwan Nuclear Receptor ROR Gamma Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Indonesia Nuclear Receptor ROR Gamma Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Thailand Nuclear Receptor ROR Gamma Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Malaysia Nuclear Receptor ROR Gamma Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Philippines Nuclear Receptor ROR Gamma Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Vietnam Nuclear Receptor ROR Gamma Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Mexico Nuclear Receptor ROR Gamma Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Brazil Nuclear Receptor ROR Gamma Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Argentina Nuclear Receptor ROR Gamma Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Turkey Nuclear Receptor ROR Gamma Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. Saudi Arabia Nuclear Receptor ROR Gamma Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. U.A.E Nuclear Receptor ROR Gamma Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. Sales Market Share of Nuclear Receptor ROR Gamma by Type (2016-2021)
Figure 53. Sales Market Share of Nuclear Receptor ROR Gamma by Application (2016-2021)
Figure 54. Sales Market Share of Nuclear Receptor ROR Gamma by Application in 2020
Figure 55. Revenue Share of Nuclear Receptor ROR Gamma by Application (2016-2021)
Figure 56. Revenue Share of Nuclear Receptor ROR Gamma by Application in 2020
Figure 57. Manufacturing Cost Structure of Nuclear Receptor ROR Gamma
Figure 58. Manufacturing Process Analysis of Nuclear Receptor ROR Gamma
Figure 59. Nuclear Receptor ROR Gamma Industrial Chain Analysis
Figure 60. Channels of Distribution
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs